Переходьте в офлайн за допомогою програми Player FM !
🎙Two Docs Talk Migraines Part 3 - Breakthroughs in Migraine Research Ep204
Manage episode 420842009 series 3310873
Discover the future of migraine management with us in our final episode of Two Docs Talk Migraines. Feel the excitement as Dr. Michael Koren and Dr. Steven Toenjes delve into a world where CGRP antagonists and pharmacogenomics interlace to tailor therapies to individual needs. We're talking about groundbreaking approaches to chronic migraine care, from the FDA-approved botulinum toxin type A, also known as Botox, to the promising horizon of nerve-stimulation devices. This is your ticket to understanding the complexities of migraine pathophysiology and the innovative clinical trials shaping the hope for relief.
Join an enlightening journey through the maze of headache treatment, where we illuminate the nuances of botulinum toxin dosing, the emergence of PACAP inhibitors, and the intriguing potential of prostaglandin-based therapies. With his profound expertise, Dr. Toenjes guides us through the patient selection process for these groundbreaking clinical trials and the profound impact research has on patient care. You're not just listening to another discussion; you're stepping into a realm where the future of migraine treatment unfolds in real-time, offering a beacon of hope to those awaiting new solutions.
Talking Topics:
- Exploring Therapeutic Options for Migraine
- Updates in Migraine Treatment and Research
Part 1: Breaking Down Headache Myths - Release Date May 15, 2024
Part 2: Treatments and Clinical Research Advancements - Release Date May 22, 2024
Part 3: Breakthroughs in Migraine Research - Release Date May 29, 2024
Recording Date: May 13, 2024
Be a part of advancing science by participating in clinical research.
Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.com
Listen on Spotify
Listen on Apple
Watch on YouTube
Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.
Follow us on Social Media:
Facebook
Instagram
Twitter
LinkedIn
Want to learn more checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com
Music: Storyblocks - Corporate Inspired
Thank you for listening!
Розділи
1. 🎙Two Docs Talk Migraines Part 3 - Breakthroughs in Migraine Research Ep204 (00:00:00)
2. Exploring Therapeutic Options for Migraine (00:00:01)
3. Updates in Migraine Treatment and Research (00:10:35)
4. Fascinating Conversation on MedEvidence (00:23:36)
244 епізодів
Manage episode 420842009 series 3310873
Discover the future of migraine management with us in our final episode of Two Docs Talk Migraines. Feel the excitement as Dr. Michael Koren and Dr. Steven Toenjes delve into a world where CGRP antagonists and pharmacogenomics interlace to tailor therapies to individual needs. We're talking about groundbreaking approaches to chronic migraine care, from the FDA-approved botulinum toxin type A, also known as Botox, to the promising horizon of nerve-stimulation devices. This is your ticket to understanding the complexities of migraine pathophysiology and the innovative clinical trials shaping the hope for relief.
Join an enlightening journey through the maze of headache treatment, where we illuminate the nuances of botulinum toxin dosing, the emergence of PACAP inhibitors, and the intriguing potential of prostaglandin-based therapies. With his profound expertise, Dr. Toenjes guides us through the patient selection process for these groundbreaking clinical trials and the profound impact research has on patient care. You're not just listening to another discussion; you're stepping into a realm where the future of migraine treatment unfolds in real-time, offering a beacon of hope to those awaiting new solutions.
Talking Topics:
- Exploring Therapeutic Options for Migraine
- Updates in Migraine Treatment and Research
Part 1: Breaking Down Headache Myths - Release Date May 15, 2024
Part 2: Treatments and Clinical Research Advancements - Release Date May 22, 2024
Part 3: Breakthroughs in Migraine Research - Release Date May 29, 2024
Recording Date: May 13, 2024
Be a part of advancing science by participating in clinical research.
Have a question for Dr. Koren? Email him at askDrKoren@MedEvidence.com
Listen on Spotify
Listen on Apple
Watch on YouTube
Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.
Follow us on Social Media:
Facebook
Instagram
Twitter
LinkedIn
Want to learn more checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com
Music: Storyblocks - Corporate Inspired
Thank you for listening!
Розділи
1. 🎙Two Docs Talk Migraines Part 3 - Breakthroughs in Migraine Research Ep204 (00:00:00)
2. Exploring Therapeutic Options for Migraine (00:00:01)
3. Updates in Migraine Treatment and Research (00:10:35)
4. Fascinating Conversation on MedEvidence (00:23:36)
244 епізодів
Tous les épisodes
×Ласкаво просимо до Player FM!
Player FM сканує Інтернет для отримання високоякісних подкастів, щоб ви могли насолоджуватися ними зараз. Це найкращий додаток для подкастів, який працює на Android, iPhone і веб-сторінці. Реєстрація для синхронізації підписок між пристроями.